Reflect Orbital's plan to launch space mirrors that beam sunlight to Earth could brighten the night sky as much as 10,000 full moons and scatter light over tens of kilometers, according to a new study…
Insilico Medicine named five humans, including CEO Alex Zhavoronkov, as inventors on a patent for a pulmonary fibrosis drug that its generative AI platform proposed, highlighting a US legal rule that …
Insilico Medicine is previewing a Virtual Aging Cell research direction that incorporates biological age into its virtual-cell models, aiming to improve predictions of cellular responses to genetic ed…
A developer demonstrated a lean AI-driven drug discovery workflow that can run in a Google Colab notebook, using open-source models like DeepMind's chemistry-diffusion to generate drug-like SMILES and…
Pathos AI, a New York City-based AI-driven drug development company, agreed to license the experimental breast cancer drug JSKN016 from China's Jiangsu Alphamab Biopharmaceutical for an upfront paymen…
Insilico Medicine announced on July 29 that the U.S. FDA granted Fast Track Designation to its AI-designed pan-TEAD inhibitor ISM6331 for adults with unresectable malignant pleural mesothelioma after …
Australia should not try to win the AI arms race but instead leverage its critical minerals and renewable energy while ensuring global tech giants pay fair tax, argues AirTree co-founder Daniel Petre.…
Anthropic has opened applications for a grant program under its AI for Science initiative, offering up to $50,000 in Claude API credits to researchers working on rare genetic diseases. The program, an…
Bora Pharmaceuticals and Insilico Medicine announced a strategic alliance valued at more than $2.5 billion if fully implemented, combining Insilico's Pharma.AI platform for drug discovery with Bora's …
Insilico Medicine's AI-discovered lung fibrosis drug, Rentosertib, has entered Phase III clinical trials for idiopathic pulmonary fibrosis, marking a rare late-stage test for AI drug discovery. The co…
The US government ordered Anthropic to suspend its Claude Fable 5 and Mythos 5 models due to jailbreak vulnerabilities reported by Amazon, then allowed their swift restoration after fixes. This interv…
MindWalk Holdings, trading as HYFT on NASDAQ, filed a European patent for its high-dimensional biological data architecture, signaling a strategic pivot as AI models become commoditized. The patent ap…
Astromech, a startup founded in 2025 by Ben Lamm and George Church, develops a Large Life Model and autonomous biological intelligence system that fuses evolutionary logic with deep learning to decode…
SK Biopharmaceuticals CEO Lee Dong-hoon announced the company is doubling down on AI and open innovation as core growth pillars, following a partnership with Insilico Medicine for AI-driven drug disco…
Insilico Medicine and SK Biopharmaceuticals announced a partnership valued at over $2.5 billion to use AI for developing neuroimmune therapies. Insilico will leverage its Pharma.AI platform for drug d…
Perceptic, a startup founded by three former Palantir executives, emerged from stealth today with $12 million in seed funding to build an end-to-end AI platform for drug development that handles every…